Testing the Promiscuity of Commercial Kinase Inhibitors Against the AGC Kinase Group Using a Split-luciferase Screen
Authors:
- 18 January 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (4) , 1526-1537
Abstract
Using a newly developed competitive binding assay dependent upon the reassembly of a split reporter protein, we have tested the promiscuity of a panel of reported kinase inhibitors against the AGC group. Many non-AGC targeted kinase inhibitors target multiple members of the AGC group. In general, structurally similar inhibitors consistently exhibited activity toward the same target as well as toward closely related kinases. The inhibition data was analyzed to test the predictive value of either using identity scores derived from residues within 6 Å of the active site or identity scores derived from the entire kinase domain. The results suggest that the active site identity in certain cases may be a stronger predictor of inhibitor promiscuity. The overall results provide general guidelines for establishing inhibitor selectivity as well as for the future design of inhibitors that either target or avoid AGC kinases.Keywords
This publication has 73 references indexed in Scilit:
- A Coiled-Coil Enabled Split-Luciferase Three-Hybrid System: Applied Toward Profiling Inhibitors of Protein KinasesJournal of the American Chemical Society, 2010
- Apparent activity in high-throughput screening: origins of compound-dependent assay interferenceCurrent Opinion in Chemical Biology, 2010
- Targeting the cancer kinome through polypharmacologyNature Reviews Cancer, 2010
- Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): Optimization and selectivity profilingBioorganic & Medicinal Chemistry, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory moduleProceedings of the National Academy of Sciences, 2007
- The multiple orthogonal tools approach to define molecular causation in the validation of druggable targetsDrug Discovery Today, 2004
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000